Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2014 - 2026)

Sarepta Therapeutics' Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $38.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 4.59% year-over-year to $38.9 million; the TTM figure through Mar 2026 stood at $294.0 million (down 81.22% YoY), while the FY2025 annual figure was $295.9 million, down 85.22% from the prior year.
• Change in Acquisitions & Divestments was $38.9 million for Q1 2026 at Sarepta Therapeutics, down from $99.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $965.1 million in Q4 2024 to a low of $38.9 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $320.5 million across 5 years, with a median of $348.7 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments surged 1231.9% in 2022, then sank 91.47% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $446.5 million in 2022, then increased by 18.3% to $528.2 million in 2023, then surged by 82.71% to $965.1 million in 2024, then plunged by 89.65% to $99.9 million in 2025, then slumped by 61.09% to $38.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $38.9 million (Q1 2026), $99.9 million (Q4 2025), and $86.6 million (Q3 2025), per Business Quant data.